Provided by Tiger Trade Technology Pte. Ltd.

Nektar Therapeutics

41.17
+0.37000.91%
Post-market: 41.170.00000.00%16:38 EDT
Volume:1.09M
Turnover:44.87M
Market Cap:1.41B
PE:-6.37
High:42.38
Open:40.38
Low:40.33
Close:40.80
52wk High:109.00
52wk Low:33.40
Shares:34.14M
Float Shares:33.55M
Volume Ratio:0.53
T/O Rate:3.24%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-6.4680
EPS(LYR):-9.7254
ROE:-35.75%
ROA:-12.54%
PB:1.56
PE(LYR):-4.23

Loading ...

Nektar price target raised to $151 from $123 at Citi

TIPRANKS
·
Apr 21

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Biogen (BIIB), Nektar Therapeutics (NKTR) and GE Healthcare Technologies Inc (GEHC)

TIPRANKS
·
Apr 21

BUZZ-Nektar starts $250 mln stock offering after alopecia treatment trial

Reuters
·
Apr 21

BRIEF-Nektar Therapeutics Announces Proposed Public Offering

Reuters
·
Apr 21

Nektar Therapeutics launches underwritten public offering of $250 million common stock

Reuters
·
Apr 21

Nektar Therapeutics - to Use Net Proceeds for R&D, Clinical Development, and General Corporate Purposes

THOMSON REUTERS
·
Apr 21

Nektar Therapeutics - Commences $250 Mln Underwritten Public Offering of Common Stock

THOMSON REUTERS
·
Apr 21

BUZZ-U.S. STOCKS ON THE MOVE-Adobe, Agios, QXO

Reuters
·
Apr 20

Wedbush Lifts Price Target on Nektar Therapeutics to $95 From $70, Maintains Neutral Rating

MT Newswires Live
·
Apr 20

Nektar rises 19.4%

TIPRANKS
·
Apr 20

Nektar Therapeutics Is Maintained at Buy by BTIG

Dow Jones
·
Apr 20

Nektar Therapeutics : Btig Raises Target Price to $178 From $151

THOMSON REUTERS
·
Apr 20

Nektar Therapeutics : H.c. Wainwright Raises Target Price to $185 From $165

THOMSON REUTERS
·
Apr 20

Nektar Therapeutics, Compass Pathways, Sila Realty Trust And Other Big Stocks Moving Higher On Monday

Benzinga_recent_news
·
Apr 20

Nektar Therapeutics Says New Rezpegaldesleukin Data Shows 'Deepening of Response' in Alopecia

MT Newswires Live
·
Apr 20

BUZZ-U.S. STOCKS ON THE MOVE-TopBuild, MDA Space, Biogen

Reuters
·
Apr 20

Nektar Therapeutics Shares up 17.8% Premarket After Alopecia Treatment Shows Promise in Extension Study

THOMSON REUTERS
·
Apr 20

Nektar Says In-Development Treatment for Hair Loss Has Promise

Dow Jones
·
Apr 20

Nektar reports new results from Phase 2b REZOLVE-AA study

TIPRANKS
·
Apr 20

Nektar Therapeutics - 29% and 31% of Patients Achieve Salt Score ≤20 From Week 36 to Week 52

THOMSON REUTERS
·
Apr 20